ENTRY       D10263            Mixture   Drug
NAME        Metformin hydrochloride and saxagliptin hydrochloride;
            Kombiglyze (TN)
PRODUCT     KOMBIGLYZE (AstraZeneca Pharmaceuticals LP)
  GENERIC   SAXAGLIPTIN AND METFORMIN (Mylan Pharmaceuticals)
            SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE (Dr.Reddys Laboratories)
COMPONENT   Metformin hydrochloride [DR:D00944], (Saxagliptin [DR:D08996] | Saxagliptin hydrochloride [DR:D10262])
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03032  Combination of metformin and DPP-4 inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      ATC code: A10BD10
            Product: D10263<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     The metabolism of saxagliptin is primarily mediated by cytochrome P450 3A4/5.
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD10 Metformin and saxagliptin
                  D10263  Metformin hydrochloride and saxagliptin hydrochloride &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Saxagliptin/ Metformin Hydrochloride
                D10263  Metformin hydrochloride and saxagliptin hydrochloride
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03032  Combination of metformin and DPP-4 inhibitor
                D10263  Metformin hydrochloride and saxagliptin hydrochloride
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10263  Metformin hydrochloride and saxagliptin hydrochloride
              DG02925  CYP3A5 substrate
               D10263  Metformin hydrochloride and saxagliptin hydrochloride
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D10263  Metformin hydrochloride and saxagliptin hydrochloride
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10263
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10263
DBLINKS     PubChem: 163312294
///
